Capreomycin in the treatment of atypical mycobacterial disease in HIV-positive patients

Eur J Clin Microbiol Infect Dis. 2002 Jul;21(7):563-5. doi: 10.1007/s10096-002-0761-x. Epub 2002 Jun 28.

Authors

K Göbels¹, J Hemker, M Oette, M Wettstein, T Heintges, D Teichmann, C R MacKenzie, D Häussinger

Affiliation

¹ Klinik für Gastroenterologie, Hepatologie und Infektiologie, Universitätsklinikum Düsseldorf, Moorenstrasse 5, 40225 Düsseldorf, Germany. goebels@med.uni-duesseldorf.de

PMID: 12172753
DOI: 10.1007/s10096-002-0761-x

No abstract available

MeSH terms

AIDS-Related Opportunistic Infections / complications
AIDS-Related Opportunistic Infections / drug therapy*
AIDS-Related Opportunistic Infections / microbiology
Adult
Antiretroviral Therapy, Highly Active
Antitubercular Agents / therapeutic use*
Capreomycin / therapeutic use*
Female
HIV Seropositivity / complications
HIV Seropositivity / microbiology
Humans
Male
Mycobacterium / isolation & purification
Mycobacterium Infections, Nontuberculous / complications*
Mycobacterium Infections, Nontuberculous / drug therapy*

Substances

Antitubercular Agents
Capreomycin